SCHEMBL14033005

SCHEMBL14033005

COC[C@@H]1NC(=O)CN(Cc2ccccc2)C1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 5/20 0.61
HDAC6 Q9UBN7 5/20 0.55
HDAC1 Q13547 4/20 0.55
HDAC8 Q9BY41 4/20 0.55
EPHX2 P34913 1/20 0.45
HDAC4 P56524 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
CCR5 P51681 1/20 0.43
TACR1 P25103 1/20 0.43
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
PKM P14618 2/20 0.39
GAA P10253 2/20 0.39
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13308352 0.87 OPRK1 (0.59) OPRK1HDAC6HDAC1HDAC8EPHX2
SCHEMBL8574805 0.86 OPRK1 (0.56) OPRK1HDAC6HDAC1HDAC8EPHX2
SCHEMBL8574802 0.86 OPRK1 (0.56) OPRK1HDAC6HDAC1HDAC8EPHX2
SCHEMBL31535467 0.86 OPRK1 (0.55) OPRK1HDAC6HDAC1HDAC8EPHX2
SCHEMBL334581 0.85 OPRK1 (0.59) OPRK1HDAC6HDAC1HDAC8EPHX2
SCHEMBL6343378 0.85 OPRK1 (0.59) OPRK1HDAC6HDAC1HDAC8EPHX2
SCHEMBL1714279 0.85 OPRK1 (0.59) OPRK1HDAC6HDAC1HDAC8EPHX2
SCHEMBL6717771 0.83 OPRK1 (0.57) OPRK1HDAC6HDAC1HDAC8KMT2A
SCHEMBL876552 0.83 HDAC6 (0.73) OPRK1HDAC6HDAC1HDAC8EPHX2
SCHEMBL877776 0.83 HDAC6 (0.73) OPRK1HDAC6HDAC1HDAC8EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed